| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 22.05.
| Celgene Corporation to Present at Sanford C. Bernstein's 28th Annual Strategic Decisions Conference | | 58 | Business Wire |
| Celgene Corporation (NASDAQ: CELG) today announced its
presentation at Sanford C. Bernstein's 28th Annual Strategic
Decisions Conference on Wednesday, May 30, 2012 at...
Mehr lesen zu:
Celgene Corporation to Present at Sanford C. Bernstein's 28th Annual Strategic Decisions Conference | |
| 18.05.
| Look for Shares of Celgene to Potentially Rebound after Yesterday's 1.40% Sell Off | | 5 | SmarTrend |
| 18.05.
| SmarTrend Watching for Potential Rebound in Shares of Celgene After 1.40% Loss | | 2 | SmarTrend |
| 16.05.
| 4-Star Stocks Poised to Pop: Celgene | | 6 | Motley Fool |
| 15.05.
| Celgene Retains Neutral Rec | | 8 | Zacks |
| 14.05.
| Celgene Earnings Hindsight: Down 2.9% in Last 18 Days | | 5 | SmarTrend |
| 10.05.
| Celgene (CELG) Unit Reports Publication of Three REVLIMID Studies in MM Patients | | 8 | StreetInsider.com |
| 08.05.
| Celgene Sets The Stage For Patient Investors | | 6 | Seeking Alpha |
| 08.05.
| Critical Alerts For General Motors, Celgene, Guess, AOL, and Cognizant Technology Released By InvestorsObserver | | 29 | PR Newswire |
| CHICAGO, May 8, 2012 /PRNewswire/ --InvestorsObserver issues critical PriceWatch Alerts for GM, CELG, GES, AOL, and CTSH.
To see what our analysts have discovered about these stocks read the InvestorsObserver's...
Mehr lesen zu:
Critical Alerts For General Motors, Celgene, Guess, AOL, and Cognizant Technology Released By InvestorsObserver | |
| 08.05.
| Aktie Celgene: Nicht ganz den Analysten entsprechend! | | 19 | MoneyMoney |
| 07.05.
| CELGENE - Das sollte reichen | | 21 | GodmodeTrader.de |
| 07.05.
| Celgene Corporation Announces Appointment of Thomas M. Moriarty as General Counsel | | 44 | Business Wire |
| Celgene Corporation (NASDAQ: CELG) today announced the appointment of
Thomas M. Moriarty as General Counsel and Corporate Secretary. In this
position, he will be responsible...
Mehr lesen zu:
Celgene Corporation Announces Appointment of Thomas M. Moriarty as General Counsel | |
| 04.05.
| Celgene Corporation to Present at Two Upcoming Investor Conferences | | 40 | Business Wire |
| Celgene Corporation (NASDAQ: CELG) announced its presentations at two
upcoming investor conferences will be webcast live and will be available
in the investor relations...
Mehr lesen zu:
Celgene Corporation to Present at Two Upcoming Investor Conferences | |
| 29.04.
| Celgene Reports Q1 Results: Seeing Further Upside | | 16 | Seeking Alpha |
| 28.04.
| Disappointed By Celgene's Q1? Take The Long View | | 12 | Seeking Alpha |
| 27.04.
| Critical Alerts For MasterCard, Celgene, Tempur-Pedic, AstraZeneca, and Sotheby's Released By InvestorsObserver | | 53 | PR Newswire |
| CHICAGO, April 27, 2012 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MA, CELG, TPX, AZN, and BID.
To see what our analysts have discovered about these stocks read the...
Mehr lesen zu:
Critical Alerts For MasterCard, Celgene, Tempur-Pedic, AstraZeneca, and Sotheby's Released By InvestorsObserver | |
| 26.04.
| Deal Announced Today Between Celgene Corporation and Epizyme, an LLS-partner, Will Help Advance a Therapy for Patients with Mixed Lineage Leukemia | | 58 | PR Newswire |
| WHITE PLAINS, N.Y., April 26, 2012 /PRNewswire/ --Thanks to funding from The Leukemia & Lymphoma Society (LLS), Epizyme has been advancing DOT1L, a targeted histone methyltransferase...
Mehr lesen zu:
Deal Announced Today Between Celgene Corporation and Epizyme, an LLS-partner, Will Help Advance a Therapy for Patients with Mixed Lineage Leukemia | |
| 26.04.
| Celgene Q1 Results Miss Estimates; But Reaffirms 2012 Outlook | | 51 | AFX News |
| SUMMIT (dpa-AFX) - Integrated biopharmaceutical company Celgene Corp. (CELG)
reported Thursday a profit for the first quarter that surged from last year,
reflecting lower expenses and double-digit...
Mehr lesen zu:
Celgene Q1 Results Miss Estimates; But Reaffirms 2012 Outlook | |
| 26.04.
| Celgene Q1 Profit Up; Backs 2012 View | | 52 | AFX News |
| SUMMIT (dpa-AFX) - Celgene Corp. (CELG) reported a growth in its
first-quarter net income to $402 million or $0.90 per share from $256 million or
$0.54 per share, with non-GAAP net income...
Mehr lesen zu:
Celgene Q1 Profit Up; Backs 2012 View | |
| 26.04.
| Epizyme Forms Strategic Partnership with Industry Leader in Epigenetic Therapies, Celgene Corporation, to Develop Personalized Therapeutics for Genetically-Defined Cancers | | 37 | Business Wire |
| – Partnership Leverages Epizyme's Transformational Histone
Methyltransferase Inhibitor Platform and Celgene's Translational
Research Capabilities –
–...
Mehr lesen zu:
Epizyme Forms Strategic Partnership with Industry Leader in Epigenetic Therapies, Celgene Corporation, to Develop Personalized Therapeutics for Genetically-Defined Cancers | |
